2؉ entry. Adenylyl cyclase catalytic activity and immunoreactivity were extracted into buoyant caveolar fractions with Triton X-100. The presence of adenylyl cyclase in such structures was eliminated by depletion of plasma membrane cholesterol. Altogether, these data lead us to conclude that adenylyl cyclase must occur in cholesterol-rich domains to be susceptible to regulation by capacitative Ca 2؉ entry. These findings are the first indication of regulatory significance for the localization of adenylyl cyclase in caveolae.
Depletion of plasma membrane cholesterol with methyl-␤-cyclodextrin did not affect forskolin-stimulated adenylyl cyclase activity and did not affect capacitative Ca 2؉ entry. However, cholesterol depletion completely ablated the regulation of adenylyl cyclase by capacitative Ca 2؉ entry. Repletion of cholesterol restored the sensitivity of adenylyl cyclase to capacitative Ca 2؉ entry. Adenylyl cyclase catalytic activity and immunoreactivity were extracted into buoyant caveolar fractions with Triton X-100. The presence of adenylyl cyclase in such structures was eliminated by depletion of plasma membrane cholesterol. Altogether, these data lead us to conclude that adenylyl cyclase must occur in cholesterol-rich domains to be susceptible to regulation by capacitative Ca 2؉ entry. These findings are the first indication of regulatory significance for the localization of adenylyl cyclase in caveolae.
Ca
2ϩ -sensitive adenylyl cyclases provide an acute focus for harmonizing the activity of Ca 2ϩ and cAMP signaling (1) . We have previously shown an absolute requirement for capacitative Ca 2ϩ entry (CCE), 1 rather than Ca 2ϩ release from stores or ionophore-mediated Ca 2ϩ entry, as the means whereby Ca 2ϩ -sensitive adenylyl cyclases are regulated by Ca 2ϩ . This regulation persists whether the cyclases are endogenously or heterologously expressed in non-excitable cells (2) (3) (4) . These findings are now being extended in a number of other systems (5) (6) (7) . These and other data led us to propose that adenylyl cyclases and CCE channels are localized in the same functional domain of the plasma membrane (4) . The mechanism for this functional colocalization is currently unknown.
A role for cytoskeletal elements in maintaining the association between CCE sites and Ca 2ϩ -sensitive adenylyl cyclases was ruled out by disruption of either actin or microtubule filaments, without a consequence for the regulation of Ca 2ϩ -sensitive adenylyl cyclases by CCE (4) . An alternative mechanism for this colocalization could be the preferential insertion of these two proteins into cholesterol-rich microdomains within the plasma membrane, such as caveolae. Caveolae, which were first described by Palade and co-workers in the 1950s (8) , are flask-shaped invaginations of the plasma membrane that are rich in cholesterol and glycosphingolipids (9) . Caveolae and, in broader terms, detergent-insoluble, glycosphingolipid-enriched domains (DIGs), 2 have been postulated to provide a platform for the concentration of signaling molecules (9, 10) . A number of the components of the cAMP-signaling cascade have been localized to caveolae, including several G-protein-coupled receptors as well as heterotrimeric G-proteins (for review see Ref. 11) . Adenylyl cyclase activity has also been reported in low density membrane fractions, from both S49 lymphoma and fibroblast cells (12) . Western blotting revealed that heterologously expressed ACIII, ACIV, and ACV in Sf9 cells were also localized to caveolin-enriched membrane fractions (13) . In cardiac tissue, ACV was coimmunoprecipitated with caveolin-3 (a resident protein of caveolae) (13) . Furthermore, caveolin modulated the activity of several of these components, such as the regulatory subunit of protein kinase A (14) and adenylyl cyclase in a type-specific fashion. For instance, caveolin inhibited ACIII and ACV but did not affect ACII (15) . The presence of the ganglioside GM1 (the receptor molecule for the entry into cells of cholera toxin, which ADP-ribosylates G-protein ␣ subunits) in caveolae is a further indication that cAMP signaling may concentrate in these structures (16) .
The identity of the channel(s) responsible for CCE is not known. Consequently, the subcellular localization of CCE is not directly discernible. However, it is notable that several proteins involved in Ca 2ϩ homeostasis, such as an InsP3 receptor-like molecule and Ca 2ϩ -ATPase, are found in caveolae (17, 18) . In endothelial cells, it has also been shown that agonist-evoked release of intracellular Ca 2ϩ originates near caveolin-rich cell edges (19) .
In the present study, we have evaluated the role of caveolae * This work was supported by Grant GM32483 from the National Institutes of Health (to D. M. F. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
‡ To whom correspondence should be addressed: Dept. of Pharmacology, Box C-236, University of Colorado Health Sciences Center, 4200 E. Ninth Ave., Denver, CO 80262. in maintaining the colocalization of CCE sites and the Ca 2ϩ -inhibitable ACVI in C6-2B glioma cells. Initial experiments showed that adenylyl cyclase activity was sensitive to cellular treatment with filipin, a cholesterol-binding agent, which suggested a potential localization in cholesterol-rich membrane domains. Electron microscopic analysis revealed morphologically identifiable caveolae along the plasma membrane. Extraction of the cells with the detergent, Triton X-100, followed by density gradient fractionation revealed that a portion of adenylyl cyclase immunoreactivity comigrated with caveolin immunostaining in buoyant membrane fractions that were consistent with cholesterol-rich membranes. Adenylyl cyclase activity also occurred in these low density fractions. Depletion of membrane cholesterol with methyl-␤-cyclodextrin (M␤CD) resulted in the retention of both adenylyl cyclase immunoreactivity and enzymatic activity in heavier, Triton-soluble fractions. In whole-cell experiments, disruption of caveolae by cholesterol depletion, using M␤CD, eliminated the ability of CCE to regulate adenylyl cyclase, without significantly affecting CCE. The regulation of adenylyl cyclase by CCE could be restored by repletion of membrane cholesterol. These results indicate that the functional colocalization of CCE channels and adenylyl cyclase activity in C6-2B cells is heavily dependent on the residence of ACVI in caveolae. Cell Culture-C6-2B rat glioma cells were maintained in 13 ml of F-10 medium (Life Technologies, Inc.) with 10% (v/v) bovine calf serum (Gemini) in 75-cm 2 flasks at 37°C in a humidified atmosphere of 95% air and 5% CO 2 . Cells were plated at approximately 70% confluence in 100-mm tissue culture dishes 2 days prior to use.
EXPERIMENTAL PROCEDURES

Materials-Thapsigargin
Cholesterol Depletion, Repletion, and Assay-Cellular cholesterol was depleted in attached C6-2B cells by washing twice with PBS, followed by incubation in F-10 media (without serum, plus 20 mM HEPES, pH 7.4) containing the indicated M␤CD concentration at 37°C for 1 h. The cells were then washed twice with PBS and used in either cell fractionation or cAMP accumulation experiments. Cholesterol repletion was performed exactly as described previously (20) . Briefly, cholesterol⅐M␤CD complexes were formed by the addition of cholesterol (6 mg dissolved in 80 l of (2:1) isopropyl alcohol:CHCl 3 ) to a stirred M␤CD solution (200 mg dissolved in 2.2 ml of H 2 O) maintained at 80°C, until clear. The complexes were then added to serum-free F-10 media to a final concentration of 0.2 mM for 45 min at 37°C. Cholesterol was measured by gas chromatography-mass spectrometry with coprostanol as internal standard, essentially as described (21) .
Measurement of cAMP Accumulation-cAMP accumulation in intact cells was measured as described previously (22) with some modifications. C6-2B cells on 100-mm dishes were incubated in F-10 medium (90 min at 37°C) with [2- 3 H]adenine (20 Ci/dish) to label the ATP pool. The cells were then washed once, detached with phosphate-buffered saline (PBS, 137 mM NaCl, 2.7 mM KCl, 10 mM Na 2 HPO 4 , and 1.8 mM KH 2 PO 4 , pH 7.4) containing EDTA (0.03%), and resuspended in a nominally Ca 2ϩ -free Krebs buffer containing 120 mM NaCl, 4.75 mM KCl, 1.44 mM MgSO 4 , 11 mM glucose, 25 mM HEPES, and 0.1% bovine serum albumin (fraction V) adjusted to pH 7.4 with 2 M Tris base. The cell suspension from one 100-mm dish was aliquoted into 12 tubes for cAMP determination. The use of Ca 2ϩ -free Krebs buffer in experiments denotes the addition of 0.1 mM EGTA to the nominally Ca 2ϩ -free Krebs buffer. All experiments were carried out at 30°C in the presence of the phosphodiesterase inhibitor, 3-isobutyl-1-methylxanthine (500 M), which was preincubated with the cells for 10 min prior to a 1-min assay. Assays were terminated by addition of 10% (w/v final) trichloroacetic acid. Markers were added to monitor the recovery of cAMP and ATP. [Ca 2ϩ ] i Measurements-C6-2B cells (10 ϫ 10 6 /ml) were loaded with fura-2/AM (2 M) plus 0.02% pluronic acid in F-10 media (without serum, containing 20 mM HEPES, 0.1% bovine serum albumin, pH 7.4) for 25 min at room temperature, as described previously (22) . The cells were then washed twice with the same media and resuspended at a concentration of 10 ϫ 10 6 cells/ml. Aliquots (400 l; 4 ϫ 10 6 cells) were pelleted, resuspended in nominally Ca 2ϩ -free Krebs buffer, and used for [Ca 2ϩ ] i measurements in a Perkin-Elmer LS50B spectrofluorimeter. Cells were pretreated with EGTA (0.1 mM) followed by the additions of thapsigargin (TG; 100 nM, at 60 s) and [Ca 2ϩ ] o (300 s), as indicated. The 340/380 nm emission ratios were converted to [Ca 2ϩ ] using the standard formula (24) .
Electron Microscopy-For morphological observation, cells were grown in plastic culture dishes made of Permanox plastic, then fixed in a mixture of 2% paraformaldehyde and 1% glutaraldehyde in a phosphate-buffered saline (PBS, 0.1 M Na 2 HPO 4 , 0.1 M NaH 2 PO 4 , 0.15 M NaCl, pH 7.2) for 20 min, and extensively washed with PBS. Cells were then post-fixed in 4% OsO 4 for 1 h followed by another brief rinse in PBS. Cells were dehydrated in a graded series of alcohol solutions (48, 70, 90, 95 , and 100% EtOH) and infiltrated overnight in a 1:1 mixture of ethanol and EPON resin. After a change to fresh, pure resin, dishes containing cells were polymerized at 60°C in an oven overnight. Small areas of the polymerized wafers were trimmed out with a razor blade and mounted on EPON blanks. Ultrathin sections were obtained from the tissue blocks and were collected on copper mesh grids. Grids were lightly counter-stained with lead citrate and uranyl acetate and were viewed and photographed with a Philips CM10 electron microscope.
Isolation of Caveolin-enriched, Detergent-resistant Membranes-Low density, Triton X-100-insoluble membranes were purified from C6-2B glioma cells using a modified protocol as described (25) . Briefly, attached cells (six 100-mm tissue culture dishes/condition) were washed with PBS, detached using PBS containing 0.03% EDTA, and pelleted by centrifugation at 1000 ϫ g for 5 min. The cell pellet was resuspended in 1 ml of ice-cold TNE (25 mM Tris-HCl, pH 7.5, 150 mM NaCl, and 5 mM EDTA) containing protease inhibitors (1 mM phenylmethylsulfonyl fluoride and 1 mM benzamidine) with or without 1% Triton X-100 and kept on ice for 30 min. Following homogenization (10 strokes with a tight fitting Dounce homogenizer), the sample was adjusted to 40% sucrose by the addition of 2 ml of 60% sucrose in TNE and placed at the bottom of a 12-ml ultracentrifuge tube containing a 5-30% (4.5 ml of each) discontinuous sucrose gradient. The gradient was centrifuged at 190,000 ϫ g (39,000 rpm) in an SW-40 rotor (16 -18 h, 4°C). Fractions (10 ϫ 1.2 ml) were collected from the top of the gradient, and the non-solubilized cell pellet was resuspended in 1.2 ml of TNE. The cell pellet required brief sonication (5 s at 50% power; Fisher Instruments Sonic Dismembrator 60) to resuspend.
Immunoblotting-Following fractionation, 400 l was taken from each fraction for precipitation of proteins using 2 mM silicotungstic acid and 5% trichloroacetic acid. Fractions were treated for 1 h on ice, and the resulting pellet was washed three times in acetone and air-dried. The pellet was resuspended in 60 l of 1% SDS for Western blotting. An additional aliquot of the non-precipitated fraction was used for protein determination using the Pierce BCA assay kit. 10 l of each precipitated fraction was used for caveolin immunoreactivity determination. Proteins were resolved using SDS-polyacrylamide gel electrophoresis and transferred to polyvinylidene difluoride membrane. The membranes were blocked in 3% milk overnight followed by incubation with caveolin antibody (Transduction Laboratories) at a final dilution of 1:2500 in TTBS (Tris-buffered saline plus 0.1% Tween 20) with 1% milk. Signal detection was achieved using horseradish peroxidase-coupled secondary antibody (Bio-Rad) followed by enhanced chemiluminescence (NEN Life Science Products) and film detection. Adenylyl cyclase immunoreactivity in the precipitated fractions was determined using a protocol from Cali et al. (26) with the following modifications. Dithiothreitol was added to 20 l of each fraction at 100 mM final concentration. The samples were heated at 80°C for 20 min and cooled to room temperature, and fresh N-ethylmaleimide was added to 60 mM. The samples were incubated at room temperature for 10 min before addition of warmed loading buffer (150 mM dithiothreitol, 10% glycerol, 62.5 mM Tris, pH 6.8, trace bromphenol blue). The entire volume was immediately loaded onto 7.5% acrylamide gels for SDS-polyacrylamide gel electrophoresis. The proteins were transferred to polyvinylidene difluoride membranes, washed in TTBS, and dried. The membrane was rewet and blocked in 10% milk for 2 h followed by incubation with adenylyl cyclase antibody (Santa Cruz Biotechnology) at a final dilution of 1:500 in TTBS plus 1% milk. Signal detection was achieved using horseradish peroxidase-coupled secondary antibody followed by en-hanced chemiluminescence (SuperSignal, Pierce) and film detection.
Adenylyl Cyclase Activity-Determination of adenylyl cyclase activity in vitro was performed as described previously (27) , with modifications. Specifically, aliquots (75 l) from each gradient fraction were assayed for adenylyl cyclase activity in the presence of the following components: 12 mM phosphocreatine, 1 unit of creatine kinase, 0.1 mM cAMP, 2 mM MnCl 2 , 0.1 mM ATP, 0.5 mM 3-isobutyl-1-methylxanthine, 50 M forskolin, 25 mM Tris, pH 7.5, and 1 Ci of [␣-
32 P]ATP. The reaction mixture (final volume, 400 l) was incubated at 30°C for 30 min. Reactions were terminated with sodium lauryl sulfate (0.5%); [ 3 H]cAMP was added as a recovery marker, and the [ 32 P]cAMP formed was quantitated according to the standard Dowex/alumina methodology (28) . Data points are presented as mean activities Ϯ S.D. of duplicate determinations.
RESULTS
Effects of Filipin on Adenylyl
Cyclase Activity-In order to probe the lipid environment of ACVI, C6-2B cells were treated with the cholesterol-binding agent filipin. Filipin is an invasive sterol-binding agent, which inserts into the membrane and binds cholesterol (29) . Filipin exerted profound inhibitory effects on adenylyl cyclase activity (Fig. 1) . The compound was quite potent, with complete inhibition of adenylyl cyclase activity at 10 g/ml. This finding strongly indicated that perturbation of cholesterol has profound consequences for adenylyl cyclase activity.
Effect of Cholesterol Depletion Using M␤CD on the Ability of CCE to Regulate ACVI-The potential contribution of cholesterol to the functional colocalization of Ca 2ϩ -sensitive adenylyl cyclases and CCE sites was assessed by cholesterol depletion experiments using M␤CD. M␤CD is non-invasive and extracts cholesterol via its hydrophobic core (29) . C6-2B cells were incubated in media without serum containing varying amounts of M␤CD at 37°C. Following this treatment, the cells were washed, and the ability of CCE to inhibit the endogenous ACVI was assessed (Fig. 2) (Fig. 2) . This graded inhibition of the cyclase mirrored the increasing CCE triggered by increasing [Ca 2ϩ ] o (4). M␤CD treatment resulted in a complete ablation of CCEmediated inhibition of the cyclase at all [Ca 2ϩ ] o , without any effect on forskolin stimulation of activity (Fig. 2) .
The cellular depletion of cholesterol by M␤CD can be reversed by forming a soluble complex of M␤CD and cholesterol, which when added to cells, leads to the incorporation of cholesterol into membranes (20) . To ascribe unequivocally the ablation of CCE-mediated inhibition of ACVI to the depletion of cholesterol, the ability of cholesterol repletion to reverse the effect was examined, as introduced by Pike and Miller (20) in their studies of EGF-stimulated PtdInsP 2 hydrolysis. Following cholesterol depletion, C6-2B cells were incubated in serumfree media containing soluble M␤CD⅐cholesterol complexes prior to cAMP determinations ( Fig. 2 ; see "Experimental Procedures"). Cholesterol repletion reversed the loss of CCE-mediated inhibition seen following cholesterol depletion, resulting in inhibition of cAMP accumulation ranging from 17 to 27% at [Ca 2ϩ ] o of 0.5 and 2 mM, respectively, which is very similar to control values.
In order to verify that M␤CD was exerting a significant effect on cholesterol levels, cholesterol content was measured as a function of M␤CD treatment by mass spectrometry of methanol extracts (see "Experimental Procedures" (21)). With increasing M␤CD concentrations, the amount of cholesterol falls to 1.9 g/100-mm dish at 15 mM M␤CD, which represents a 70% decrease from control values (Fig. 3) .
A possible explanation for the ablation by M␤CD of CCEmediated inhibition of adenylyl cyclase could have been a com- 
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promising of CCE. This issue was addressed in experiments with Fura-2-loaded populations of C6-2B cells that had been treated (or not) with M␤CD, as in Fig. 2 (Fig. 4) ] i rise that was similar between control and M␤CD-treated cells. The control and M␤CD-treated cells reached peak [Ca 2ϩ ] i values of ϳ550 and 500 nM, respectively. (Note, cAMP accumulation was measured over the 1-min period corresponding to 300 -360 s in the Ca 2ϩ trace, where there is no discernible difference between the two conditions; see Fig. 2.) Since M␤CD had little effect on either CCE or forskolinstimulated adenylyl cyclase activity, but substantially reduced the ability of CCE to regulate the cyclase, it seemed reasonable to conclude that, for their functional interaction, the CCE channel and the adenylyl cyclase might be localized within a cholesterol-rich domain. Caveolae are rich in cholesterol as well as sphingolipids and could provide an identifiable, morphological domain for the localization of ACVI (31). Caveolae are not found in all cell types. Consequently, electron microscopy was used to determine whether C6-2B cells possess morphological structures resembling caveolae. Caveolae could clearly be seen, as indicated by the invaginations of the plasma membrane (not shown). The diameter of these structures was ϳ50 -100 nm, which is consistent with previously reported dimensions of caveolae (32, 33) . Additionally, the distribution of invaginated caveolae was irregular along the plasma membrane, consistent with the presumed transient nature of these structures (9) . Confirmation of caveolar morphology in these cells stimulated our further investigations of the role of caveolae in maintaining the functional association between CCE sites and adenylyl cyclase.
The molecular nature of the CCE channel is not known, and its subcellular localization cannot be determined by immunohistochemistry, for example. However, given that the CCE channel and adenylyl cyclase are functionally colocalized (4) and that this interaction is susceptible to cholesterol disruption, the localization of ACVI in cholesterol-rich domains could be pursued using cell fractionation techniques. Caveolae and cholesterol-rich regions in general can be isolated by several methods, including mechanical disruption (sonication) or detergent insolubility. In the present case, the insolubility of caveolae in Triton X-100 at 4°C, a property due to the high content of cholesterol and sphingolipids present in caveolae (31) , was exploited using a protocol similar to that of Lisanti et al. (25) . 4 In this procedure, membrane proteins that occur in phospholipid-rich regions are solubilized by the detergent; membrane proteins that are in cholesterol-rich regions are not solubilized but are separated from the solubilized proteins by their greater buoyancy (25) (cell debris and non-solubilized material sediment). C6-2B cells were resuspended in TNE buffer containing protease inhibitors with or without 1% Triton X-100 and kept on ice for 30 min (see "Experimental Procedures"). Following homogenization, the samples were brought to 40% sucrose and placed beneath a 5-30% discontinuous sucrose gradient and centrifuged. The gradients were then fractionated and analyzed. The Western blots for both caveolin 
and adenylyl cyclase from cells not solubilized with Triton X-100 are shown (Fig. 5) . Both caveolin and adenylyl cyclase staining was found only in the cell pellet. Upon Triton X-100 solubilization, the majority of caveolin immunoreactivity occurred at ϳ15-20% sucrose (fractions 4 and 5). Much of the adenylyl cyclase staining also moved to lighter sucrose densities following solubilization, comigrating with caveolin ( Fig. 5 ).
Adenylyl cyclase activity was also measured in the fractions following detergent solubilization as above (Fig. 5) . As expected from the immunoblotting data, the non-detergent-treated cells exhibited adenylyl cyclase activity only on the bottom of the gradient, 5 whereas Triton X-100 treatment caused a migration of some adenylyl cyclase activity to lower sucrose densities, coinciding with the caveolin staining (Fig. 6 ). When the specific activity was examined (Fig. 6, inset) , the adenylyl cyclase activity migrating at low sucrose concentrations following detergent treatment was much higher than that seen at higher sucrose concentrations (fraction 5, 130 pmol/mg⅐min versus fraction 9, 10 pmol/mg⅐min). Fig. 6B shows the protein profile along with the sucrose concentrations for each of the fractions. Triton extraction caused only a modest redistribution of total protein to the low density fractions. However, a substantial amount of adenylyl cyclase activity was found there. These results indicate that much of the adenylyl cyclase is localized within Triton-insoluble membrane domains.
To determine whether the attenuating effects of M␤CD on CCE regulation of ACVI would be reflected in altered sedimentation of adenylyl cyclase, cells were fractionated following M␤CD treatment. Prior to the Triton X-100 treatment of the cell suspension, attached cells were incubated in serum-free media with or without M␤CD for 1 h at 37°C. Following homogenization, the sample was again brought to 40% sucrose, placed at the bottom of a 5-30% discontinuous sucrose gradient, and centrifuged. The gradient was fractionated as above, and aliquots of the individual fractions were subjected to Western blot analysis (Fig. 7) . As in Fig. 5 , Triton X-100 solubilization resulted in the majority of caveolin staining migrating to lighter fractions (ϳ15-20% sucrose) with a small portion remaining in the cell pellet (data not shown). Similarly, much of the adenylyl cyclase staining also moved to lower sucrose densities. When cells were depleted of cholesterol using M␤CD, adenylyl cyclase staining was confined to the pellet (Fig. 7) . Therefore, the analogous M␤CD treatment that had reduced the ability of CCE to inhibit adenylyl cyclase activity in wholecell experiments also precluded the adenylyl cyclase staining from moving to lighter sucrose concentrations. Examination of the adenylyl cyclase activity in the same fractions mirrored the immunoblot data 5 ( Fig. 8) . Triton X-100 treatment released a portion of the cyclase activity to lighter densities, whereas M␤CD treatment blocked this effect. Comparing the specific activities (Fig. 8, inset) , Triton X-100 treatment alone resulted in substantial activity in buoyant fractions, whereas M␤CD treatment prior to Triton X-100 solubilization precluded adenylyl cyclase activity from floating into lighter fractions. 6 
DISCUSSION
The present study has explored the role of cholesterol-rich domains in sustaining the functional colocalization between a Ca 2ϩ -sensitive adenylyl cyclase and CCE channels in C6-2B cells. The adenylyl cyclase activity was potently inhibited by filipin, a cholesterol-binding agent. Fractionation following Triton X-100 extraction of the cells revealed a comigration of caveolin and adenylyl cyclase activity and immunoreactivity in buoyant, Triton-insoluble membrane fractions. The occurrence of the adenylyl cyclase (and caveolin) in these buoyant fractions was precluded by depletion of cellular cholesterol using M␤CD. In intact cells, cholesterol depletion eliminated the ability of CCE to regulate the cyclase, without affecting Ca 2ϩ entry due to CCE. The effect of CCE on adenylyl cyclase was restored by replenishing cellular cholesterol. Therefore, the presence of a Ca 2ϩ -sensitive adenylyl cyclase in caveolae seems important for its regulation by physiological Ca 2ϩ entry through CCE channels. These results are analogous to the findings by Pike and Miller (20) in which disruption of cholesterol-rich domains with M␤CD in A431 cells led to an inhibition in EGF-and bradykinin-stimulated PtdInsP 2 turnover, accompanied by a loss of EGF receptor, G q , and PtdInsP 2 from the low density membrane domains. The authors also saw a graded response to cholesterol depletion. Depleting cellular cholesterol by only 20% resulted in an approximate 50% loss in EGF-or bradykinin-stimulated PtdInsP 2 turnover. Furthermore, replacement of cellular cholesterol led to a reestablishment of hormonestimulated PtdInsP 2 hydrolysis. Similarly, cholesterol deple- 5 Adenylyl cyclase activity is apparent in fractions 9 and 10, but adenylyl cyclase immunoreactivity is not apparent in these same fractions. It turns out that the relatively high Triton X-100 concentration used in the membrane solubilization procedure interfered with efficient trichloroacetic acid precipitation of the solubilized protein. When SDS is included during the trichloroacetic acid precipitation, at a ratio of Triton X-100 to SDS of 0.67, as described by Chang (54), adenylyl cyclase immunoreactivity is observed in fractions 9 and 10 (data not shown, n ϭ 3). 6 Note that the relative amount of adenylyl cyclase activity in the caveolin-enriched fractions following Triton X-100 solubilization is lower when compared with the heavier fractions. This result contrasts with the data presented in Fig. 6 where the amount of cyclase activity was similar in fractions 5 and 9. The difference in these experiments was that in Fig. 8 , cells were incubated in serum-free media for 1 h to facilitate the removal of cholesterol by M␤CD prior to Triton X-100 solubilization. The apparent redistribution might reflect a decrease in cellular cholesterol due to a lack of low density lipoprotein in serum-free media, which delivers cholesterol to the cell (55). 
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tion with cyclodextrin resulted in the loss of morphologically recognizable caveolar structures in 3T3-L1 adipocytes, and a concomitant loss in insulin receptor signaling, which could be reversed by exogenous replenishment of cholesterol (34) . Therefore, cholesterol-rich domains may not only concentrate signaling molecules but also underpin functional coupling between them.
By both Western analysis and activity measurements, ACVI occurred in buoyant Triton-insoluble membrane fractions that also displayed caveolin immunostaining. However, only a portion of the cyclase was localized in these domains. Nevertheless, the subpopulation of adenylyl cyclase in the Triton-insoluble membrane fractions seemed responsible for the majority of the Ca 2ϩ -regulated adenylyl cyclase activity in vivo. This conclusion stems from the fact that the same cholesterol-depleting protocol, using M␤CD, resulted in both an elimination of inhibition by CCE of adenylyl cyclase in whole-cell experiments along with a loss of adenylyl cyclase activity and immunostaining from the Triton-insoluble, low density membrane fractions. This observation raises the possibility that there are two pools of ACVI, one in cholesterol-rich domains that can be regulated by CCE, whereas the other is excluded from cholesterol-rich domains and is not regulated by CCE. 7 Of course, the present findings also suggest that at least some CCE channels are preferentially found in cholesterol-rich domains.
The two pools of adenylyl cyclase may be dynamic and interchangeable with the proper stimulus. In this regard, the B2 bradykinin and the m2 muscarinic receptors localize within caveolae in an agonist-stimulated fashion (35) (36) (37) . The reverse appears to be the case for the EGF and adenosine A1 receptors, which are rapidly moved out of caveolae upon binding EGF (38) or adenosine A1 receptor agonists (39), respectively. Certain 
isoforms of protein kinase C are also dynamically localized to caveolae. Protein kinase C␣, unlike protein kinase C⑀, associates with caveolae in a Ca 2ϩ -dependent manner (40) . eNOS provides an elegant example of regulated caveolar localization. When eNOS is present in caveolae, its activity is inhibited by binding caveolin. Ca 2ϩ stimulation of eNOS causes the enzyme to translocate from caveolae. As [Ca 2ϩ ] i returns to basal levels, eNOS activity is inhibited as it moves back into caveolae and reassociates with caveolin (41) . eNOS is also acylated by the fatty acids myristate and palmitate, which promote its residence in caveolae (42, 43) (as does the acylation of several other molecules, including G-proteins (44)). It would be interesting in future studies to determine whether the presence of adenylyl cyclase in such domains could be regulated dynamically.
Although the role of Ca 2ϩ signaling in caveolae has only been explored sparingly, molecules have been found in caveolae that would suggest a role in Ca 2ϩ homeostasis, such as an InsP 3 receptor-like protein (17, 45) , Ca 2ϩ -ATPase (18), and calmodulin (46) . Although the concept of InsP 3 -activated Ca 2ϩ entry at the plasma membrane has been controversial, it has been shown to have a role in lymphocytes and olfactory neurons (47) (48) (49) . In endothelial cells, agonist-evoked Ca 2ϩ release, either via ATP or bradykinin, originates in caveolin-rich regions (19) . PtdInsP 2 , the precursor for InsP 3 , has also been localized within Triton-insoluble membranes (50) . In a recent review, Isshiki and Anderson (51) proposed that caveolae could comprise Ca 2ϩ signaling units, in which mechanisms for both Ca 2ϩ entry into the cytosol and Ca 2ϩ resequestration are present. It is interesting to remember that caveolae are also dynamic organelles, that pinch off from the plasma membrane in their role in potocytosis (52) . Caveolae, while in the cytosol, could contain high intracompartmental Ca 2ϩ , due to prior exposure to the extracellular space, which would allow them to be mobile Ca 2ϩ stores. This, coupled with the presence of several Ca 2ϩ -sensitive signaling enzymes on the caveolar membrane, could provide a mobile signaling platform (51) .
Protein colocalization in microdomains has become an increasingly prevalent concept. It offers an efficient means for colocalizing parallel but interacting signaling systems. In the case of a Ca 2ϩ -sensitive adenylyl cyclase, colocalization with CCE channels ensures acute responsiveness to a very discrete Ca 2ϩ signal. From the present study, the functional colocalization of Ca 2ϩ entry sites and the Ca 2ϩ -sensitive adenylyl cyclase seems to be underpinned by their residence in a cholesterolrich lipid environment. The same functional colocalization occurs with heterologously expressed adenylyl cyclases (3). If cholesterol-rich domains seem equally important in those systems, it will provide the possibility of identifying the mechanism involved, since putative targeting domains of adenylyl cyclases can be manipulated in heterologous expression systems. It is also important to stress that, whereas the presence of Ca 2ϩ -sensitive adenylyl cyclases and CCE channels in cholesterol-rich domains may aid in explaining the dependence of adenylyl cyclases on this form of Ca 2ϩ rise, it does not explain how cyclases cannot respond to a significant release of Ca 2ϩ from intracellular stores (2) . Conceivably, an array of mobile and immobile Ca 2ϩ buffers (53) could serve both to contain the Ca 2ϩ signal emanating from the CCE channel and to exclude Ca 2ϩ arising from cytosolic sources. Much remains to be known of the microenvironment surrounding critical signaling molecules. 
